Sign in Subscribe
Colorectal cancer

Repeated Enema Administration in Rhesus Macaques Does Not Promote Bacterial Dysbiosis or Gastrointestinal Dysfunction

Strategic Insights

— 1 min read

Research from the National Institute of Allergy and Infectious Diseases (NIAID) has shed new light on the effects of repeated enema administration in rhesus macaques on their fecal microbiome and intestinal immunity. The study, published in Mucosal Immunology, aimed to investigate whether repeated clearance of the colonic microbiome could induce persistent changes in the microbiome, intestinal immunity, and viral disease susceptibility.

Key Takeaways:

  • The study involved 16 rhesus macaques that received repeated iso-osmolar enemas before being challenged with simian immunodeficiency virus (SIV).
  • The research found no significant changes in the fecal microbiome or intestinal immune parameters of treated animals.
  • Despite the lack of changes, enema-treated animals exhibited significantly lower setpoint viral loads after SIV infection.
  • The study's findings suggest that repeated microbiome clearance using iso-osmolar enemas is not sufficient to promote bacterial dysbiosis or gastrointestinal dysfunction.
  • The research framework developed in this study may serve as a model for the development of colonic-administered diagnostics and interventions.

Statistics:

  • 16 rhesus macaques were used in the study.
  • The animals received repeated iso-osmolar enemas before SIV challenge.
  • The study found no significant changes in fecal microbiome diversity or composition.
  • Enema-treated animals exhibited a 30% reduction in setpoint viral loads after SIV infection.
  • The study's findings suggest that repeated enema administration is not sufficient to induce persistent changes in the fecal microbiome or intestinal immunity.

Sources:

  • Repeated enema administration in rhesus macaques is not sufficient to promote bacterial dysbiosis or gastrointestinal dysfunction. Mucosal Immunology, 2025;18(5):1036-1046.
  • National Institute of Allergy and Infectious Diseases (NIAID). Barrier Immunity Section, Laboratory of Viral Diseases.
  • National Institutes of Health. Bethesda, MD 20892, United States.

Read more